Home NDC 24430-1003 NDC 24430-1003 - Kinlytic This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 24430-1003
Package NDCs from labels 24430-1003-1
Manufacturer ImaRx Therapeutics, Inc.
Effective date 2007-06-08
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 24430-1003-1 Kinlytic 5 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 5 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 24430-1003 KINLYTIC (UROKINASE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [IMARX THERAPEUTICS, INC.] 1 1 package rows 20080813_BFE5CFB9-591D-4DF8-12A3-6555CDE3185D.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded UROKINASE ACTIVE INGREDIENT 83G67E21XI KINLYTIC (UROKINASE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [IMARX THERAPEUTICS, INC.] 1 urokinase ACTIVE MOIETY 83G67E21XI KINLYTIC (UROKINASE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [IMARX THERAPEUTICS, INC.] 1 albumin (human) INACTIVE INGREDIENT KINLYTIC (UROKINASE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [IMARX THERAPEUTICS, INC.] 1 MANNITOL INACTIVE INGREDIENT 3OWL53L36A KINLYTIC (UROKINASE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [IMARX THERAPEUTICS, INC.] 1 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X KINLYTIC (UROKINASE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [IMARX THERAPEUTICS, INC.] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.